Oncology Blogs
12|18|25
Beyond the Abstract: Four Converging Trends from ASH 2025
The American Society of Hematology (ASH) Annual Meeting is more than a forum for groundbreaking science; it is a barometer for the future of oncology. The key takeaways from ASH 2025 signal a fundamental shift in the hematologic cancer landscape, driven by a convergence of powerful forces. Download the POV to learn more.
12|01|25
The Oncologist’s Next Ally: Why Cancer Is Forging the Future of Clinical AI
Cancer care is driving the next wave of clinical AI innovation. In this POV, Barry Vucsko reveals why oncology stands as the ultimate testing ground for technologies poised to transform the entire healthcare ecosystem. For pharma marketers, understanding these seismic shifts isn’t just valuable—it’s vital for staying ahead of the curve.
06|13|25
AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era
At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]
06|10|25
AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025
At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care.
04|30|25
More Complexity, Less Protection: Why Oncology Brands are Redefining for Survival
The pace of change in oncology is accelerating—and with it, the pressure on brands to adapt. From scientific advancements and precision medicine to shifting standards of care and practice consolidation, oncology is no longer just complex—it’s chaotic. Oncologists are overwhelmed and the once-protected status of oncology is now in question. Brands that fail to evolve […]
09|27|24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Every year, ESMO brings together experts from pharma, research and advocacy organizations, and HCPs to hear about the year’s biggest oncology breakthroughs. This year’s theme was “Shaping the Future of Anticancer Therapies.”